Develops implantable drug delivery technologies designed to provide long‑duration dosing for chronic diseases. Its NanoPortal platform is being studied to deliver therapies such as GLP‑1 receptor agonists for diabetes and obesity through small subdermal implants that release medication over months. ...
1 member of Congress has disclosed 1 trade in VANI (VANI), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-03-20 | Rohit Khanna | sell | $1K – $15K |